SCHEMBL7427902

SCHEMBL7427902

CSC1(C)C(=O)Nc2ccc(C(C)=O)cc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.50
PDE3B Q13370 2/20 0.46
PDE3A Q14432 2/20 0.46
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46
PDE4C Q08493 1/20 0.46
PDE4D Q08499 1/20 0.46
IP6K1 Q92551 1/20 0.39
IDO1 P14902 2/20 0.38
GAA P10253 2/20 0.37
MAPT P10636 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
TLK2 Q86UE8 4/20 0.36
SLC2A1 P11166 1/20 0.36
MEN1 O00255 1/20 0.36
CYBB P04839 1/20 0.36
APP P05067 1/20 0.36
ALOX15 P16050 1/20 0.36
SNCA P37840 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7428391 0.83 PDE4A (0.43) PGRPDE3BPDE3APDE4APDE4B
SCHEMBL7438531 0.76 PGR (0.50) PGRPDE3BPDE3AIP6K1IDO1
SCHEMBL7438527 0.75 PGR (0.52) PGRPDE3BPDE3AIP6K1IDO1
SCHEMBL20268826 0.73 IP6K1 (0.55) PGRPDE3BPDE3APDE4APDE4B
SCHEMBL20268320 0.73 IP6K1 (0.55) PGRPDE3BPDE3APDE4APDE4B
SCHEMBL7836579 0.72 PDK2 (0.60) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL1764545 0.71 HDAC3 (0.54) PGRIP6K1GAAMAPTNPC1
SCHEMBL1874397 0.68 PGR (0.55) PGRPDE3BPDE3APDE4APDE4B
SCHEMBL27076405 0.68 MAPT (0.45) PGRGAAMAPTNPC1RAB9A
SCHEMBL9462366 0.68 KDM4E (0.55) PGRPDE3BPDE3ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4933336-A Thiadiazinone, oxadiazinone and triazinone derivatives, and their use for treating acute or chronic heart disease LABORATOIRES SOBIO S.A. (FR) 1990-06-12 US disclosed
EP-0303418-A2 Substituted indolones, useful in the treatment of heart or asthmatic diseases SMITHKLINE BEECHAM LABORATOIRES PHARMACEUTIQUES (FR) 1989-02-15 EP disclosed